Single-Cell Transcriptome Profiling of Mouse and hESC-Derived Pancreatic Progenitors

Stem Cell Reports. 2018 Dec 11;11(6):1551-1564. doi: 10.1016/j.stemcr.2018.11.008.

Abstract

Human embryonic stem cells (hESCs) are a potential unlimited source of insulin-producing β cells for diabetes treatment. A greater understanding of how β cells form during embryonic development will improve current hESC differentiation protocols. All pancreatic endocrine cells, including β cells, are derived from Neurog3-expressing endocrine progenitors. This study characterizes the single-cell transcriptomes of 6,905 mouse embryonic day (E) 15.5 and 6,626 E18.5 pancreatic cells isolated from Neurog3-Cre; Rosa26mT/mG embryos, allowing for enrichment of endocrine progenitors (yellow; tdTomato + EGFP) and endocrine cells (green; EGFP). Using a NEUROG3-2A-eGFP CyT49 hESC reporter line (N5-5), 4,462 hESC-derived GFP+ cells were sequenced. Differential expression analysis revealed enrichment of markers that are consistent with progenitor, endocrine, or previously undescribed cell-state populations. This study characterizes the single-cell transcriptomes of mouse and hESC-derived endocrine progenitors and serves as a resource (https://lynnlab.shinyapps.io/embryonic_pancreas) for improving the formation of functional β-like cells from hESCs.

Keywords: CyT49; Neurog3; cell therapy; diabetes; endocrine progenitors; hESCs; mT/mG; pancreas development; scRNA-seq.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Differentiation
  • Cell Lineage
  • Embryo, Mammalian / cytology
  • Human Embryonic Stem Cells / metabolism*
  • Humans
  • Mice
  • Mouse Embryonic Stem Cells / metabolism*
  • Pancreas / cytology*
  • RNA / metabolism
  • Single-Cell Analysis*
  • Time Factors
  • Transcriptome / genetics*

Substances

  • RNA